Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

PharmaFocus & Canadian Market Access Advisor

Active
cb-189-19598216International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Government of Canada → Patented Medicine Prices Review BoardView Agency

NAICS

N/A

Place of Performance

National Capital Region (NCR), CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Patented Medicine Prices Review Board
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Patented Medicine Prices Review Board
View Agency Profile
Office AddressN/A
Contacts
Sylvie BeaudoinContracting Authority

Full Description

Show more
The PMPRB requires drug information respecting quantities and revenue of medicines sold in Canada. The information must be collected in a complete, objective and non-biased fashion by surveying hospitals, pharmacies and wholesalers across Canada. The PMPRB also requires publications and associated subscription services that provide regular updates on federal and provincial/territorial policy changes related to pharmaceuticals, public drug plan design and coverage, prices and developments of the Common Drug Review and the recommendations of the Canadian Expert Drug Advisory Committee; as well as information on the latest Notice of Compliance as well as statistics and intelligence on the Canadian pharmaceutical market.